Interpreting dual-sugar absorption studies in critically ill patients: what are the implications of apparent increases in intestinal permeability to hydrophilic solutes?
Fink
M P
MP
D000818:Animals; D018988:Bacterial Translocation; D002241:Carbohydrates / Q000493:pharmacokinetics*; D016638:Critical Illness; D004195:Disease Models, Animal; D004298:Dopamine / Q000031:analogs & derivatives / Q000494:pharmacology; D006801:Humans; D007239:Infections / Q000635:transmission; D007408:Intestinal Absorption / Q000187:drug effects / Q000502:physiology*; D007413:Intestinal Mucosa / Q000187:drug effects / Q000502:physiology*; D007792:Lactulose / Q000493:pharmacokinetics; D010539:Permeability / Q000187:drug effects; D012210:Rhamnose / Q000493:pharmacokinetics; D013045:Species Specificity
D002241:Carbohydrates; D007792:Lactulose; D012210:Rhamnose; D004298:Dopamine